Long‐term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.30992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Jonathan Kiekenap und 7 weiteren Autor:innen. Beteiligte Einrichtung: DHZC (Deutsches Herzzentrum der Charité), Charité - University Medicine, Berlin, Germany. Hauptthemen laut MEDLINE: Pulmonary Valve, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Federal Ministry for Economic Affairs and Climate Action.
Abstract (Originalsprache)
Background
Current heart valve implants entail major disadvantages in the treatment for younger patients or those with congenital heart defects.
Aim
Evaluation of novel transcatheter pulmonary valve implant made from autologous pericardium with natural crosslinking agent in an in vitro setup and in vivo animal model Methods Valves were tested in a pulse duplicator according to ISO‐standard 5840. For in vivo studies computer tomography was performed to measure sheep's native pulmonary valve dimensions. Pericardium was harvested by thoracotomy, personalized implants were manufactured and deployed in pulmonary valve position of the same sheep. Every 3 months implant functionality was evaluated by intracardiac echocardiography, intracardiac pressure measurements and cardiac magnetic resonance imaging (cMRI). Implants were explanted for macroscopic and histological examination.
Results
In vitro experiments showed compliance with regulatory requirements in terms of valve opening and insufficiency. Five sheep successfully received an autologous valve implant. Two animals had to be euthanized due to trauma sustained in the stable. Long‐term valve function was excellent in three out of four animals with median implant cMRI regurgitation fraction of 9% ( n = 4) at 3 months, 8% ( n = 3) at 6, 8% ( n = 3) at 9, 12% ( n = 3) at 13, 8% ( n = 2) at 17% and 8% ( n = 2) at 20.5 months after implantation. Despite good adherence to neighboring tissue and endothelization, histological assessment revealed some signs of degeneration.
Conclusion
Transcatheter pulmonary valve implants showed promising function for up to 20.5 months encouraging research to further improve this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DHZC (Deutsches Herzzentrum der Charité), Charité - University Medicine, Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
- BIH (Berlin Institute of Health), Berlin, Germany.
- BCRT (BIH Center of Regenerative Therapies), Berlin, Germany.
ORCID-Profile: Jonathan Kiekenap, Boris Schmitt
Förderung
- German Federal Ministry for Economic Affairs and Climate Action
Zitieren
APA
Kiekenap, J., Sun, X., Hao, Y., Steitz, M., Breitenstein-Attach, A., Emeis, J., Berger, F., & Schmitt, B. (2024). Long‐term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30992
Vancouver
Kiekenap J, Sun X, Hao Y, Steitz M, Breitenstein-Attach A, Emeis J, et al. Long‐term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30992
BibTeX
@article{Kiekenap2024,
author = {Kiekenap, Jonathan and Sun, Xiaolin and Hao, Yimeng and Steitz, Marvin and Breitenstein-Attach, Alexander and Emeis, Jasper and Berger, Felix and Schmitt, Boris},
title = {Long‐term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.30992}
}
EUVIMED